Expression of the multidrug resistance gene in human prostate cancer

Urologic Oncology

Volumn 5, Issue 3, 2000, Pages 118-121

  Bhangal, G ^a   Halford, S ^a   Wang, J ^a   Roylance, R ^a   Shah, R ^a   Waxman, J ^a  

^a Science and Technology   (United Kingdom)

Author keywords

Drug resistance; Immunocytochemistry; P glycoprotein; Prostate cancer

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY;

EID: 0034607381     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(99)00055-1     Document Type: Article

References (24)

1. Cancer Statistics Registrations, 1990 Series MB1 No. 23. Washington, DC: Office for National Statistics, 1997.
2. Mortality Statistics: Cause 1995 Series DH2 No. 22. 1997;Office for National Statistics, Washington, DC.
3. Savage P., Bates C., Abel P., Waxman J. British urological surgery practice. 1. Prostate cancer Br J Urol. 79:1997;749-755.
4. Nicholson S., Waxman J. Prostate cancer and endocrine therapy. Endocr Relat Cancer. 4:1997;141-152.
5. Bower M., Waxman J. Gene therapy for prostate cancer. Semin Cancer Biol. 8:1997;3-9.
6. Chen C.J., Chin J.E., Ueda K.et al. Internal duplication and homology with bacterial transport proteins in the MDR1 (p-glycoprotein) gene from multidrug resistant human cells. Cell. 47(3381-9):1986.
7. Endicott J.A., Ling V. The biochemistry of p-glycoprotein mediated multidrug resistance. Annu Rev Biochem. 58:1989;137-171.
8. Ernest S., Rajaraman S., Megyesi J., Bello-Reuss E.N. Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron. 77(3):1997;284-289.
9. Udea K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full length cDNA for the human MDR1 (p-glycoprotein) gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 84(9):1987;3004-3008.
10. Schinkel A.H., Roelofs E.M., Borst P. Characterisation of the human MDR3 p-glycoprotein and its recognition by p-glycoprotein specific monoclonal antibodies. Cancer Res. 51(10):1991;2628-2635.
11. Kohno K., Sato S., Takano H., Matsuo K., Kuwano M. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun. 165(3):1989;1415-1421.
12. Cordon-Cardo C., O'Brien J.P., Boccia D., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (p-glycoprotein) in human normal and tumour tissues. J Histochem Cytochem. 38(9):1990;1277-1287.
13. Cordon-Cardo C., O'Brien J.P., Casals D., Bertino J.P., Melamed M.R. Immunoanatomic and immunopathologic expression of multidrug resistance gene product. Furth M., Greaves M. Cancer Cells, Volume 7, Molecular Diagnostics of Human Cancer. 1989;87-94 Cold Spring Harbor Laboratory, New York.
14. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localisation of the multidrug resistance gene product p-glycoprotein in normal human tissues. Proc Natl Acad Sci USA. 84(21):1987;7735-7738.
15. Georges E., Bradley G., Gariepy J., Ling V. Detection of p-glycoprotein isoforms by gene specific monoclonal antibodies. Proc Natl Acad Sci USA. 87(1):1990;152-156.
16. Konishi N., Hiasa Y., Matsuda H.et al. Intratumour cellular heterogeneity and alterations in ras oncogene and p53 tumour suppressor gene in human prostate carcinoma. Am J Pathol. 147(4):1995;1112-1122.
17. Sakr W.A., Macoska J.A., Benson P.et al. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res. 54(12):1994;3273-3277.
18. Izbicka E., Dalton W.S., Troyer D., Von Hoff D.D. Expression of two multidrug resistance genes in human prostatic carcinomas. J Natl Cancer Inst. 90(2):1998;166-167.
19. Fojo A.T., Ueda K., Slamon D.J., Poplack D.G., Gottesman M.M., Pastan I. Expression of a multidrug resistance gene in human tumours and tissues. Proc Natl Acad Sci USA. 84(1):1987;265-269.
20. Van der Valk P., Van Kalken C.K., Ketelaars H.et al. Distribution of multi-drug resistance-associated p-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the p-glycoprotein molecule. Ann Oncol. 1(1):1990;56-64.
21. Goldstein L.J., Galski H., Fojo A.et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 81(2):1989;116-124.
22. Siegsmund M.J., Kreukler C., Steidler A., Nelse T., Kohrmann K.U., Alken P. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urol Res. 25(1):1997;35-41.
23. Tannock I.F., Osoba D., Stockler M.R.et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer. a Canadian randomized trial with palliative end points J Clin Oncol. 14(6):1996;1756-1764.
24. Trock B.J., Leonessa F., Clarke R. Multidrug resistance in breast cancer. a meta-analysis of MDR1/gp170 expression and its possible functional significance J Natl Cancer Inst. 89(13):1997;917-931.